Why Your Health Insurance Premiums Keep Going Up, And Why 2026 Is Different
Whether your coverage comes through your employer or Medicare and a Supplement plan, you’ve probably noticed your premiums are climbing faster than usual. You’re not wrong. Health insurance costs are rising at rates that outpace inflation, wage growth, and most household budgets, and the reasons behind it go well beyond the standard “healthcare is expensive” explanation. Here’s what’s actually driving the increases and what it means for you.
The Numbers Tell the Story
For people on employer-sponsored plans, the average cost of family coverage hit $26,993 in 2025, a 6% jump in a single year. A research group projects group health insurance costs will rise another 8.5% in 2026, and without employer negotiations to push rates down, that number would be closer to 9%. At that pace, employer health premiums could double within a decade.
For Medicare Supplement (Medigap) holders, the hit has been even sharper. Rate increases for Plan G, the most popular Medigap policy, ranged from 12% to more than 26% in early 2026 filings from major carriers including Aetna, Blue Cross Blue Shield, Cigna, Humana, Mutual of Omaha, and UnitedHealthcare, according to Nebraska-based actuarial firm Telos Actuarial. Some policyholders have seen increases of 18–22% in a single renewal cycle.
So why is this happening?
Reason #1: The Underlying Cost of Healthcare Is Exploding
This is the root cause that flows into every premium you pay. Medical inflation, the rising cost of services, procedures, drugs, and hospital stays, jumped roughly 8% in 2024, with some forecasting another 8.5% increase heading into 2026. Compare that to overall consumer inflation sitting around 2.4–2.9%, and you can see healthcare is inflating at a completely different pace than the rest of the economy. The American Hospital Association’s 2025 Costs of Caring report puts it plainly: total hospital expenses grew 7.5% in 2025, more than twice the rate of growth in what hospitals actually charge. Supply costs jumped nearly 10%, and drug spending rose 13.6%. Insurers absorb those costs and then pass them to you through higher premiums. It’s that simple. Medicare Part B premiums also reflect this reality, rising to $202.90 per month in 2026, up from $185 the prior year. Medigap carriers look at those same underlying cost trends when setting their own rates, which is why supplement plan increases mirror what’s happening in the broader healthcare market.
Reason #2: The Healthcare Workforce Crisis Is Baked Into Every Policy
You can’t deliver healthcare without healthcare workers, and the U.S. doesn’t have enough of them. Workforce spending is hospitals’ single largest expense, accounting for roughly 60% of total hospital costs. In 2025, those costs rose another 5.6%. Registered nurse salaries have grown 26.6% faster than inflation over the past four years. The Association of American Medical Colleges projects a shortage of up to 124,000 physicians in the coming years. When there aren’t enough workers, hospitals pay premium rates for contract and travel staff, a bill that hit $51.1 billion in 2023 alone. Those costs don’t disappear. They get priced into what insurers pay for every hospital stay, every procedure, every ER visit. For Medigap policyholders and employees on group plans alike, higher hospital operating costs translate directly into higher claims and higher premiums at renewal.
Reason #3: GLP-1 Drugs Are Reshaping What Insurance Costs
Few developments have rattled insurers more than the explosion of GLP-1 medications, drugs like Ozempic, Wegovy, Mounjaro, and Zepbound, originally developed for Type 2 diabetes and now wildly popular for weight loss. These drugs cost $900 to $1,300 per month and the market for them is massive. More than 57 million privately insured adults are clinically eligible for GLP-1 medications. Usage has grown from 6.9% of insurance claims in 2023 to 10.5% in 2025, and for more than a quarter of employers, these drugs now account for over 15% of annual drug claims. Research from Blue Cross Blue Shield found that covering GLP-1 medications could raise RX premiums by as much as 14% from this one drug category alone.
Medicare Part D members are now eligible for discounted copay prices for GLP-1 medications that are used for weight loss. Please click on this link for the article that explains the Bridge program details.
Reason #4: Prescription Drug Costs Are Accelerating Across the Board
GLP-1s are the headline, but the prescription drug problem runs much deeper. National drug spending grew 10% in 2024, outpacing other medical cost categories, while clinical drugs like infusions rose even faster at 14%. For Medigap policyholders, Part D premiums and drug costs factor into overall Medicare spending trends that insurers track when pricing supplement plans. Cancer, the top cost driver for health plans four years running, is driving both higher treatment costs and new, expensive therapies that insurers are now covering. Musculoskeletal conditions, cardiovascular disease, and diabetes round out the top four, each bringing their own high-cost treatment pathways.
Reason #5: Tariffs Adding a New Layer of Cost Pressure
This one is newer and still unfolding. An estimated 62% of medical devices used in the U.S. come from other countries, and about 70% of US-marketed devices are manufactured entirely outside the United States. China is the top import source for healthcare supplies, followed by Europe and Canada. Tariffs on those supply chains put hospitals in a tough spot. They can absorb the costs, difficult for facilities already operating on thin margins, or eventually pass them through. Several insurers have already cited tariff-related uncertainty in announcing premium increases for 2026, and those figures are likely to grow as supply chain impacts compound.
Reason #6: Aging Demographics Are Driving More Utilization
The American population is getting older, and older people use more healthcare. Americans aged 55 and older make up about 30% of the population but account for a disproportionately large share of healthcare spending. For Medigap plans specifically, this hits the hardest. The pool of Medicare beneficiaries using supplement plans is aging in place, meaning carriers are covering increasingly complex, higher-cost patients year after year.
What This Means for Medicare Supplement Policyholders
For retirees on Medigap, the calculus is different but no less serious. Supplement premiums are rising sharply, with Plan G seeing 12–26% increases in many states, while the underlying benefits remain the same. The Part B premium increase to $202.90, the Part B deductible rising to $283, and higher overall claims costs are all putting pressure on carriers to reprice. If you’re already on a Medigap plan and facing a large renewal increase, shopping for a lower rate is worth exploring, but approval is not guaranteed outside your initial enrollment window.
The Bottom Line
Rising health insurance premiums, whether you’re on a group plan through your employer or a Medicare Supplement policy, aren’t the result of one bad year. They’re the compounding output of structural forces: a healthcare workforce that costs more to maintain, drug prices that bear no relationship to what other countries pay, an aging population generating more complex and expensive claims, supply chains disrupted by tariffs, and a pharmaceutical market introducing high-cost therapies at a record pace. None of those pressures has a fast fix. The most important thing you can do right now is understand what’s driving your costs, compare your options during open enrollment or renewal.
Our Medicare Support Services team is here to help you find options that work for you. Contact us anytime at 940-382-4700.
